Jumpcan Pharmaceutical Group
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Jumpcan Pharmaceutical Group
Scrip
• By Dexter Jie Yan
Chinese drug makers are upping their game in the race to develop a homegrown follower of Shionogi & Co. Ltd. and Roche Holding AG ’s oral influenza antiviral Xofluza (baloxavir marboxil), as Joinc
Scrip
• By Joseph Haas and Jung Won Shin
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis